ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AZTA Azenta Inc

54.94
0.99 (1.84%)
11 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Azenta Inc AZTA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.99 1.84% 54.94 10:00:00
Open Price Low Price High Price Close Price Previous Close
53.30 53.30 55.38 54.94 53.95
more quote information »

Recent News

Date Time Source Heading
05/6/202406:05PRNUSAzenta Announces Collaboration with the Crohn's & Colitis..
30/5/202422:01EDGAR2Form SD - Specialized disclosure report
24/5/202406:05PRNUSAzenta to Participate in the Jefferies Global Healthcare..
23/5/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202407:48EDGAR2Form 144 - Report of proposed sale of securities
14/5/202406:46PRNUSAzenta Opens the Doors to Its New Genomics Laboratory in..
10/5/202406:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:00EDGAR2Form 8-K - Current report
09/5/202406:15EDGAR2Form 8-K - Current report
09/5/202406:06PRNUSAzenta Announces CEO Succession Plan
09/5/202406:05PRNUSAzenta Reports Second Quarter Results for Fiscal 2024, Ended..
02/5/202406:05PRNUSAzenta Announces Fiscal 2024 Second Quarter Earnings..
02/4/202407:15PRNUSAzenta Publishes its 2023 Environmental, Social, &..
02/4/202407:05PRNUSAzenta to Participate in the 23rd Annual Needham Virtual..
12/3/202423:00PRNUSAzenta to Participate in the Virtual KeyBanc Life Sciences &..
12/3/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202408:38EDGAR2Form 144 - Report of proposed sale of securities
08/3/202408:26EDGAR2Form 144 - Report of proposed sale of securities
15/2/202406:51EDGAR2Form 144 - Report of proposed sale of securities
14/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202408:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/2/202407:34EDGAR2Form 144 - Report of proposed sale of securities
08/2/202408:21EDGAR2Form 8-K - Current report
08/2/202408:05PRNUSAzenta Reports First Quarter Results for Fiscal 2024, Ended..
03/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202400:00PRNUSAzenta Launches the BioArcâ„¢ Ultra, a Breakthrough, Automated..
02/2/202408:10EDGAR2Form 8-K - Current report
02/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202408:34EDGAR2Form 8-K - Current report
26/1/202408:05PRNUSAzenta Announces Fiscal 2024 First Quarter Earnings..
25/1/202406:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202408:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/1/202408:05EDGAR2Form 8-K - Current report
12/1/202408:05PRNUSAzenta to Host Investor Day on March 14, 2024
12/1/202408:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/1/202408:05PRNUSAzenta to Participate in the 26th Annual Needham Growth..
04/1/202408:05PRNUSAzenta to Participate in the 42nd Annual J.P. Morgan..
16/12/202308:41EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/12/202308:34EDGAR2Form DEF 14A - Other definitive proxy statements
07/12/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202309:21EDGAR2Form 144 - Report of proposed sale of securities
06/12/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..